# A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer

> clinical trial · VERIFIED · 2026-07-22

Status: RECRUITING · Sponsor: AbbVie · Condition: Small Cell Lung Cancer

- Company: AbbVie
- Sector: Small Cell Lung Cancer
- Primary source: https://clinicaltrials.gov/study/NCT07155174

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.